Immunoassays News and Research

RSS

Lateral flow assays detect a compound of interest in a compact, paper-based system. Tests such as pregnancy tests are based on lateral flow assays, with many more available for various compounds or even pathogens.

Laser irradiation boosts antibody-antigen interactions to detect colorectal cancer

Researchers often use antibodies to detect specific molecules or biological markers, as they are remarkably precise at recognizing their targets.

25 Sep 2026

Spear Bio to unveil novel Alzheimer’s disease immunoassays and fully automated instrument platform at AAIC 2026

Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced plans to unveil new SPEAR immunoassay and instrument innovations at the Alzheimer’s Association International Conference® 2026, taking place July 12–15 in London, UK.

From Spear Bio 9 Jul 2026

Direct-to-definitive toxicology screening: Moving beyond immunoassays in clinical toxicology

Discover expert insights into toxicology screening with mass spectrometry, reducing false results and improving patient safety in clinical toxicology.

From Waters Advanced Diagnostics 9 Jul 2026

Streamlining immunological research using VIAFLO 96 and VIAFLO 384 handheld electronic pipettes

An immunology research group at an Ivy League university is using the VIAFLO 96 and VIAFLO 384 handheld electronic pipettes from INTEGRA Biosciences to streamline its ELISA workflows.

From INTEGRA Biosciences 3 Jun 2026

Why clinical proteomics faces a mass spectrometry vs. high-throughput profiling dilemma

This Clinical Chemistry and Laboratory Medicine review examines a central challenge in precision medicine: whether medical laboratories should prioritize metrologically sound, proteoform-resolving protein quantification by mass spectrometry or adopt scalable, affinity-based proteome profiling platforms built for high-throughput discovery and machine learning. It concludes that while emerging proteomics technologies expand diagnostic possibilities, careful validation, standardization, and quality assurance will be essential, with a hybrid path likely offering the most practical way forward.

19 Apr 2026

Bio-Techne introduces streamlined brand architecture to help customers navigate solutions faster and with greater clarity

Bio-Techne Corporation, a global provider of life science research tools, analytical instruments, and diagnostics, today announced a streamlined brand architecture designed to enable scientists and clinicians to more easily find the answers they need based on their application and stage of research.

From Bio-Techne 16 Apr 2026

Spear Bio introduces new ultra-sensitive neurodegenerative assays and expands direct access at AD/PD 2026

Spear Bio, an innovator in ultrasensitive protein biomarker detection, showcased three new SPEAR UltraDetect™ immunoassays—brain-derived p-Tau 217 (BD-pTau 217), α-synuclein (α-syn) and phospho-Ser129-α-synuclein (pS129-α-syn)—at the International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 2026) last week.

From Spear Bio 26 Mar 2026

Siemens Healthineers launches brain health research portfolio with first biomarker assays now available

Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for 1.

From Siemens Healthineers 19 Mar 2026

New blood biomarker may detect Alzheimer’s pathology more accurately

Researchers compared total plasma pTau217 with a brain-derived pTau217 assay to determine which better identifies Alzheimer’s disease–related amyloid and tau pathology. Brain-derived pTau217 showed strong diagnostic performance and appeared less affected by kidney dysfunction, supporting its potential as a more specific blood biomarker for Alzheimer’s disease.

3 Mar 2026

Chimpanzee urine confirms widespread alcohol consumption in the wild

Aleksey Maro knows far more than he cares to know about the urination habits of chimpanzees. But if you want to measure the alcohol intake of chimps in a Ugandan rain forest, where a breathalyzer is impractical, collecting urine for analysis is your only choice.

24 Feb 2026

Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly in regions with high hepatitis B virus prevalence.

24 Jan 2026

Adding lean pork to a plant-forward diet supports healthy aging biomarkers

A randomized crossover feeding trial in adults aged 65 years or older found that plant-forward diets incorporating either minimally processed lean pork or lentils produced similar short-term improvements in cardiometabolic and neuroactive biomarkers. Both diets supported metabolic health and functional stability, with no overall adverse biomarker effects attributable to including minimally processed red meat within a Dietary Guidelines–aligned pattern.

19 Jan 2026

Formulatrix® and Spear Bio advance automated ultrasensitive protein detection through ongoing partnership

Formulatrix, a leader in laboratory automation solutions, and Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced their ongoing partnership to automate and optimize the SPEAR UltraDetect™ assay platform using the F.A.S.T.™ (Flow Axial Seal Tip) Liquid Handler.

From Spear Bio 15 Jan 2026

Finger-prick blood test shows promise for detecting Alzheimer’s disease biology

Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and NfL, showing strong concordance with venous plasma and meaningful associations with CSF pathology. While analytical limitations remain, this minimally invasive approach shows promise as a scalable research and screening tool within biomarker-based diagnostic pathways.

6 Jan 2026

Thermo Fisher Scientific expands neurodegeneration research capabilities with launch of Olink® Target 48 Neurodegeneration panel

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research.

From Olink®- Part of Thermo Fisher Scientific 3 Oct 2025

Two-step blood and scan strategy delivers near-perfect accuracy for early Alzheimer's signs

Plasma p-tau217 testing can help detect preclinical Alzheimer disease in cognitively unimpaired adults. Using it as a first-line screen followed by positron emission tomography or cerebrospinal fluid testing boosts accuracy, reduces false positives, and streamlines recruitment.

16 Sep 2025

SLIT2 protein levels in the eye and blood linked to cognitive function

Neurocognitive impairments are classified by pathological changes with potential for destruction of neural tissue. One change known to occur in neurodegenerative disorders is an accumulation of proteins causing pathological damage.

11 Sep 2025

Rose petal-inspired sensors revolutionize wearable sweat monitoring

Wearable sensors can help prevent critical health issues by continuously monitoring physiological factors in real time.

28 Aug 2025

Spear Bio announces strategic partnership with Bio-Techne to accelerate the deployment of its next-generation immunoassay technology

Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation, a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics.

From Spear Bio 5 Aug 2025

Spear Bio launches next generation ultrasensitive immunoassay solution SPEAR UltraDetect™ to transform neurodegenerative disease research

Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its SPEAR UltraDetect™ immunoassay solution. It delivers unparalleled sensitivity, specificity, precision, and scalability for robust biomarker measurement.

From Spear Bio 5 Aug 2025

Immunoassays News and Research

Further Reading

Laser irradiation boosts antibody-antigen interactions to detect colorectal cancer

Spear Bio to unveil novel Alzheimer’s disease immunoassays and fully automated instrument platform at AAIC 2026

Direct-to-definitive toxicology screening: Moving beyond immunoassays in clinical toxicology

Streamlining immunological research using VIAFLO 96 and VIAFLO 384 handheld electronic pipettes

Why clinical proteomics faces a mass spectrometry vs. high-throughput profiling dilemma

Bio-Techne introduces streamlined brand architecture to help customers navigate solutions faster and with greater clarity

Spear Bio introduces new ultra-sensitive neurodegenerative assays and expands direct access at AD/PD 2026

Siemens Healthineers launches brain health research portfolio with first biomarker assays now available

New blood biomarker may detect Alzheimer’s pathology more accurately

Chimpanzee urine confirms widespread alcohol consumption in the wild

Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Adding lean pork to a plant-forward diet supports healthy aging biomarkers

Formulatrix® and Spear Bio advance automated ultrasensitive protein detection through ongoing partnership

Finger-prick blood test shows promise for detecting Alzheimer’s disease biology

Thermo Fisher Scientific expands neurodegeneration research capabilities with launch of Olink® Target 48 Neurodegeneration panel

Two-step blood and scan strategy delivers near-perfect accuracy for early Alzheimer's signs

SLIT2 protein levels in the eye and blood linked to cognitive function

Rose petal-inspired sensors revolutionize wearable sweat monitoring

Spear Bio announces strategic partnership with Bio-Techne to accelerate the deployment of its next-generation immunoassay technology

Spear Bio launches next generation ultrasensitive immunoassay solution SPEAR UltraDetect™ to transform neurodegenerative disease research

Biochemical Assays for Efficient Hit Prioritization After Screening eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo